Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2013, Article ID 125264, 6 pages
http://dx.doi.org/10.1155/2013/125264
Research Article

Cryoglobulins as Potential Triggers of Inflammation in Schizophrenia

Institute of Molecular Biology, National Academy of Sciences of the Republic of Armenia (NAS RA), 7 Hasratyan Street, 0014 Yerevan, Armenia

Received 25 July 2013; Revised 3 October 2013; Accepted 11 October 2013

Academic Editor: Luis San

Copyright © 2013 Andranik Chavushyan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Rothermundt, V. Arolt, and T. A. Bayer, “Review of immunological and immunopathological findings in schizophrenia,” Brain, Behavior, and Immunity, vol. 15, no. 4, pp. 319–339, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Müller and M. J. Schwarz, “The role of immune system in schizophrenia,” Current Immunology Reviews, vol. 6, no. 3, pp. 213–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. U. Meyer, M. J. Schwarz, and N. Müller, “Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond,” Pharmacology and Therapeutics, vol. 132, no. 1, pp. 96–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. B. J. Miller, P. Buckley, W. Seabolt, A. Mellor, and B. Kirkpatrick, “Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects,” Biological Psychiatry, vol. 70, no. 7, pp. 663–671, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Boyajyan, R. Zakharyan, and A. Khoyetsyan, “Molecular and genetic indicators of aberrant immunity and apoptosis in schizophrenia,” in Schizophrenia Research: Recent Advances, T. Sumiyoshi, Ed., pp. 183–240, Nova Science, New York, NY, USA, 2012. View at Google Scholar
  6. M. D. Richard and N. C. Brahm, “Schizophrenia and the immune system: pathophysiology, prevention, and treatment,” The American Journal of Health-System Pharmacy, vol. 69, no. 9, pp. 757–766, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. B. García-Bueno, M. Bioque, K. S. Mac-Dowell et al., “Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia,” Schizophrenia Bulletin, 2013. View at Publisher · View at Google Scholar
  8. D. R. Hanson and I. I. Gottesman, “Theories of schizophrenia: a genetic-inflammatory-vascular synthesis,” BMC Medical Genetics, vol. 6, article 7, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Boyajyan, A. Khoyetsyan, G. Tsakanova, and R. B. Sim, “Cryoglobulins as indicators of upregulated immune response in schizophrenia,” Clinical Biochemistry, vol. 41, no. 6, pp. 355–360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Takada, T. Shimizu, Y. Hadano et al., “Cryoglobulinemia (review),” Molecular Medicine Reports, vol. 6, no. 1, pp. 3–8, 2012. View at Google Scholar
  11. M. Ramos-Casals, J. H. Stone, M. C. Cid, and X. Bosch, “The cryoglobulinaemias,” The Lancet, vol. 379, no. 9813, pp. 348–360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. U. Kallemuchikkal and P. D. Gorevic, “Evaluation of cryoglobulins,” Archives of Pathology and Laboratory Medicine, vol. 123, no. 2, pp. 119–125, 1999. View at Google Scholar · View at Scopus
  13. S. M. Weiner, V. Prasauskas, D. Lebrecht, S. Weber, H. H. Peter, and P. Vaith, “Occurrence of C-reactive protein in cryoglobulins,” Clinical and Experimental Immunology, vol. 125, no. 2, pp. 316–322, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Lamprecht, “Cryoglobulinaemic vasculitis: new aspects,” Clinical and Experimental Rheumatology, vol. 30, no. 1, supplement 70, pp. S3–S5, 2012. View at Google Scholar
  15. J. C. Brouet, J. P. Clauvel, F. Danon, M. Klein, and M. Seligmann, “Biologic and clinical significance of cryoglobulins. A report of 86 cases,” The American Journal of Medicine, vol. 57, no. 5, pp. 775–788, 1974. View at Google Scholar · View at Scopus
  16. L. Mathsson, A. Tejde, K. Carlson et al., “Cryoglobulin-induced cytokine production via FcγRIIa: inverse effects of complement blockade on the production of TNF-α and IL-10. Implications for the growth of malignant B-cell clones,” The British Journal of Haematology, vol. 129, no. 6, pp. 830–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Katila, B. Appelberg, M. Hurme, and R. Rimon, “Plasma levels of interleukin-1β and interleukin-6 in schizophrenia, other psychoses, and affective disorders,” Schizophrenia Research, vol. 12, no. 1, pp. 29–34, 1994. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Maes, L. B. Chiavetto, S. Bignotti et al., “Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor,” Schizophrenia Research, vol. 54, no. 3, pp. 281–291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Kunz, K. M. Ceresér, P. D. Goi et al., “Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance,” Revista Brasileira de Psiquiatria, vol. 33, no. 3, pp. 268–274, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. The International Statistical Classification of Diseases and Related Health Problems, World Health Organization, Geneva, Switzerland, 10th edition, 1992.
  21. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publications, American Psychiatric Association, Washington, DC, USA, 4th edition, 2000.
  22. M. B. First, R. L. Spitzer, M. Gibbon, and J. B. W. Williams, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Non-Patient Edition (SCID-I/NP), Biometrics Research, New York State Psychiatric Institute, New York, NY, USA, 2001.
  23. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  24. S. Kasugai, N. Hasegawa, and H. Ogura, “A simple in vito cytotoxicity test using the MTT (3-(4,5)-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) colorimetric assay: analysis of eugenol toxicity on dental pulp cells (RPC-C2A),” Japanese Journal of Pharmacology, vol. 52, no. 1, pp. 95–100, 1990. View at Google Scholar · View at Scopus
  25. R. Zakharyan and A. Boyajyan, “Inflammatory cytokine network in schizophrenia,” World Journal of Biological Psychiatry, 2013. View at Publisher · View at Google Scholar
  26. J. Kowalski, P. Blada, K. Kucia, A. Madej, and Z. S. Herman, “Neuroleptics normalize increased release of interleukin-1β and tumor necrosis factor-α from monocytes in schizophrenia,” Schizophrenia Research, vol. 50, no. 3, pp. 169–175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Di Nicola, A. Cattaneo, N. Hepgul et al., “Serum and gene expression profile of cytokines in first-episode psychosis,” Brain, Behavior, and Immunity, vol. 31, pp. 90–95, 2013. View at Publisher · View at Google Scholar
  28. R. Zanardini, L. Bocchio-Chiavetto, C. Scassellati et al., “Association between IL-1β-511C/T and IL-1RA (86bp)n repeats polymorphisms and schizophrenia,” Journal of Psychiatric Research, vol. 37, no. 6, pp. 457–462, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Paul-Samojedny, M. Kowalczyk, R. Suchanek et al., “Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia—a case-control study,” Journal of Molecular Neuroscience, vol. 42, no. 1, pp. 112–119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Almoguera, R. Riveiro-Alvarez, J. Lopez-Castroman et al., “ATA homozigosity in the IL-10 gene promoter is a risk factor for schizophrenia in Spanish females: a case control study,” BMC Medical Genetics, vol. 12, article 81, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. F. W. Lung, M. C. Yang, and B. C. Shu, “The interleukin 10 promoter haplotype ACA and the long-form variant of the DRD4 uVNTR polymorphism are associated with vulnerability to schizophrenia,” Psychiatry Research, vol. 188, no. 2, pp. 294–296, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Denys, I. A. Udalova, C. Smith et al., “Evidence for a dual mechanism for IL-10 suppression of TNF-α production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-κB in primary human macrophages,” Journal of Immunology, vol. 168, no. 10, pp. 4837–4845, 2002. View at Google Scholar · View at Scopus
  33. L. Mathsson, J. Lampa, M. Mullazehi, and J. Rönnelid, “Immune complexes from rheumatoid arthritis synovial fluid induce FcγRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-α by peripheral blood mononuclear cells,” Arthritis Research and Therapy, vol. 8, no. 3, article R64, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Bacle, N. Haeffner-Cavaillon, M. Laude, C. Couturier, and M. D. Kazatchkine, “Induction of IL-1 release through stimulation of the C3b/C4b complement receptor type one (CR1, CD35) on human monocytes,” Journal of Immunology, vol. 144, no. 1, pp. 147–152, 1990. View at Google Scholar · View at Scopus
  35. L. B. Klickstein, S. F. Barbashov, T. Liu, R. M. Jack, and A. Nicholson-Weller, “Complement receptor type 1 (CR1, CD35) is a receptor for C1q,” Immunity, vol. 7, no. 3, pp. 345–355, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. R. S. Selvan, H. B. Kapadia, and J. L. Platt, “Complement-induced expression of chemokine genes in endothelium: regulation by IL-1-dependent and -independent mechanisms,” Journal of Immunology, vol. 161, no. 8, pp. 4388–4395, 1998. View at Google Scholar · View at Scopus
  37. K. R. Mayilyan, D. R. Weinberger, and R. B. Sim, “The complement system in schizophrenia,” Drug News and Perspectives, vol. 21, no. 4, pp. 200–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. Z. Khalkhali-Ellis, G. A. Bulla, L. S. Schlesinger, D. A. Kirschmann, T. L. Moore, and M. J. C. Hendrix, “C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors,” Journal of Immunology, vol. 163, no. 8, pp. 4612–4620, 1999. View at Google Scholar · View at Scopus